The M53A1 was developed by Avon to counter military unique and domestic threats encountered on the modern battlefield, the global war on terrorism, and peacekeeping operations around the world.
According to Avon Protection, the M53A1 gas mask provides protection against traditional chemical and biological agents, select toxic industrial chemicals (TICs), and particulate matter including radioactive dust.
The M53A1 can function as a conventional negative pressure or air purifying respirator (APR), powered-air purifying respirator (PAPR), self-contained breathing apparatus (SCBA), closed-circuit breathing apparatus (CCBA) and combination SCBA and PAPR systems.
Work locations and funding will be determined with each order, with an estimated completion date of March 24, 2024.